{"id":"NCT01797445","sponsor":"Gilead Sciences","briefTitle":"Study to Evaluate the Safety and Efficacy of E/C/F/TAF Versus E/C/F/TDF in HIV-1 Positive, Antiretroviral Treatment-Naive Adults","officialTitle":"A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-03-12","primaryCompletion":"2014-09-19","completion":"2018-10-03","firstPosted":"2013-02-22","resultsPosted":"2016-01-08","lastUpdate":"2020-03-02"},"enrollment":872,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["HIV","HIV Infections"],"interventions":[{"type":"DRUG","name":"E/C/F/TAF","otherNames":["Genvoya®"]},{"type":"DRUG","name":"E/C/F/TDF","otherNames":["Stribild®"]},{"type":"DRUG","name":"E/C/F/TDF Placebo","otherNames":[]},{"type":"DRUG","name":"E/C/F/TAF Placebo","otherNames":[]}],"arms":[{"label":"E/C/F/TAF (Double-Blind)","type":"EXPERIMENTAL"},{"label":"E/C/F/TDF (Double-Blind)","type":"ACTIVE_COMPARATOR"},{"label":"Open-Label E/C/F/TAF","type":"EXPERIMENTAL"}],"summary":"The primary objective of this study is to evaluate the efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) fixed-dose combination (FDC) versus elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate (E/C/F/TDF) in HIV-1 positive, antiretroviral treatment-naive adults.","primaryOutcome":{"measure":"Percentage of Participants Achieving HIV-1 RNA < 50 Copies/mL at Week 48","timeFrame":"Week 48","effectByArm":[{"arm":"E/C/F/TAF","deltaMin":91.6,"sd":null},{"arm":"E/C/F/TDF","deltaMin":88.5,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.13"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":14,"exclusionCount":13},"locations":{"siteCount":117,"countries":["United States","Canada","Dominican Republic","France","Italy","Mexico","Netherlands","Portugal","Puerto Rico","Sweden","United Kingdom"]},"refs":{"pmids":["25890673","29627709","28282300","28076335","26892863","27742226","26829661"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":54,"n":431},"commonTop":["Diarrhoea","Headache","Upper respiratory tract infection","Nausea","Nasopharyngitis"]}}